✦ LIBER ✦

Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children

✍ Scribed by Audino Podda; Erminia Carapella^De Luca; Lucina Titone; Anna Maria Casadei; Antonio Cascio; Marcella Bartalini; Gianfranco Volpini; Samuele Peppoloni; Ilio Marsili; Luciano Nencioni; Rino Rappuoli

Book ID: 117162963
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 322 KB
Volume: 123
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(05)81543-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acellular pertussis vaccine composed of

Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: Safety and immunogenicity in 12- to 24- and 2- to 4-month-old children

✍ Audino Podda; Erminia Carapella De Luca; Lucina Titone; Anna Maria Casadei; Anto 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 475 KB

A novel process for preparing an acellul

A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin

✍ Larry U.L. Tan; Raafat E.F. Fahim; Gail Jackson; Kimberly Phillips; Po Wah; Dirk 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 557 KB

Phase I clinical trial of an acellular p

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa

✍ Audino Podda; Luciano Nencioni; Ilio Marsili; Samuele Peppoloni; Gianfranco Volp 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 477 KB

Effect of priming with diphtheria and te

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children

✍ Audino Podda; Gianni Bona; Gianpaolo Canciani; Anna Maria Casadei Pistilli; Brun 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Immunogenicity and safety of a pertussis

Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children

✍ Ingela Krantz; Ronald Sekura; Birger Trollfors; John Taranger; Gunilla Zackrisso 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 449 KB

Safety and immunogenicity of two inactiv

Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants

✍ Scott A. Halperin; H.Dele Davies; Luis Barreto; Roland Guasparini; William Meeki 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 674 KB